Search Results

There are 97885 results for: content related to: Prostate-specific antigen velocity (PSAV) risk count improves the specificity of screening for clinically significant prostate cancer

  1. You have free access to this content
    Interpretation of the prostate-specific antigen history in assessing life-threatening prostate cancer

    BJU International

    Volume 106, Issue 9, November 2010, Pages: 1284–1292, Anna E. Kettermann, Luigi Ferrucci, Bruce J. Trock, E. Jeffrey Metter, Stacy Loeb and H. Ballentine Carter

    Version of Record online : 10 MAY 2010, DOI: 10.1111/j.1464-410X.2010.09363.x

  2. You have free access to this content
    Is the utility of prostate-specific antigen velocity for prostate cancer detection affected by age?

    BJU International

    Volume 101, Issue 7, April 2008, Pages: 817–821, Stacy Loeb, Kimberly A. Roehl, William J. Catalona and Robert B. Nadler

    Version of Record online : 5 MAR 2008, DOI: 10.1111/j.1464-410X.2008.07501.x

  3. You have free access to this content
    The utility of prostate-specific antigen velocity thresholds in clinical practice: a population-based analysis

    BJU International

    Volume 101, Issue 12, June 2008, Pages: 1507–1512, David Connolly, Amanda Black, Liam J. Murray, Thiagarajan Nambirajan, Patrick F. Keane and Anna Gavin

    Version of Record online : 13 MAR 2008, DOI: 10.1111/j.1464-410X.2008.07470.x

  4. You have free access to this content
    Prostate-specific antigen kinetics in localized and advanced prostate cancer

    BJU International

    Volume 103, Issue 5, March 2009, Pages: 578–587, John M. Fitzpatrick, Eugeniu Banu and Stephane Oudard

    Version of Record online : 6 FEB 2009, DOI: 10.1111/j.1464-410X.2009.08345.x

  5. You have free access to this content
    Comprehensive analysis of post-diagnostic prostate-specific antigen kinetics as predictor of a prostate cancer progression in active surveillance patients

    BJU International

    Volume 111, Issue 3, March 2013, Pages: 396–403, Viacheslav Iremashvili, Murugesan Manoharan, Soum D. Lokeshwar, Daniel L. Rosenberg, David Pan and Mark S. Soloway

    Version of Record online : 15 JUN 2012, DOI: 10.1111/j.1464-410X.2012.11295.x

  6. The utility of PSA velocity in prediction of prostate cancer and high grade cancer after an initially negative prostate biopsy

    The Prostate

    Volume 73, Issue 16, December 2013, Pages: 1796–1802, Ahmed ElShafei, Yong-Hong Li, Asmaa Hatem, Ayman S. Moussa, Vargo Ethan, Nirmal Krishnan, Jianbo Li and J. Stephen Jones

    Version of Record online : 29 AUG 2013, DOI: 10.1002/pros.22718

  7. Prediagnostic prostate-specific antigen kinetics and the risk of biopsy progression in active surveillance patients

    International Journal of Urology

    Volume 23, Issue 4, April 2016, Pages: 313–317, Viacheslav Iremashvili, Shane L Barney, Murugesan Manoharan, Bruce R Kava, Dipen J Parekh and Sanoj Punnen

    Version of Record online : 13 JAN 2016, DOI: 10.1111/iju.13048

  8. You have free access to this content
    Prostate-specific antigen (PSA) and PSA velocity for prostate cancer detection in men aged <50 years

    BJU International

    Volume 99, Issue 4, April 2007, Pages: 753–757, Leon Sun, Judd W. Moul, James M. Hotaling, Edward Rampersaud, Phillipp Dahm, Cary Robertson, Nicholas Fitzsimons, David Albala and Thomas J. Polascik

    Version of Record online : 22 JAN 2007, DOI: 10.1111/j.1464-410X.2006.06682.x

  9. You have free access to this content
    Prostate-specific antigen velocity and prostate cancer gleason grade and stage

    Cancer

    Volume 109, Issue 8, 15 April 2007, Pages: 1689–1695, Paul F. Pinsky, Gerald Andriole, E. David Crawford, David Chia, Barnett S. Kramer, Robert Grubb, Robert Greenlee and John K. Gohagan

    Version of Record online : 1 MAR 2007, DOI: 10.1002/cncr.22558

  10. You have free access to this content
    Usefulness of prostate-specific antigen velocity in screening for prostate cancer

    International Journal of Urology

    Volume 9, Issue 6, June 2002, Pages: 316–321, Kazuto Ito, Takumi Yamamoto, Masaru Ohi, Yutaka Kubota, Yoshitatsu Fukabori, Kohei Kurokawa, Kazuhiro Suzuki and Hidetoshi Yamanaka

    Version of Record online : 24 SEP 2008, DOI: 10.1046/j.1442-2042.2002.00466.x

  11. You have free access to this content
    Prostate-specific antigen (PSA) kinetics in untreated, localized prostate cancer: PSA velocity vs PSA doubling time

    BJU International

    Volume 103, Issue 7, April 2009, Pages: 872–876, Michael K. Ng, Nicholas Van As, Karen Thomas, Ruth Woode-Amissah, Alan Horwich, Robert Huddart, Vincent Khoo, Alan Thompson, David Dearnaley and Chris Parker

    Version of Record online : 17 OCT 2008, DOI: 10.1111/j.1464-410X.2008.08116.x

  12. You have free access to this content
    PROSTATE-SPECIFIC ANTIGEN VELOCITY (PSAV) RISK COUNT IMPROVES THE SPECIFICITY OF SCREENING FOR CLINICALLY SIGNIFICANT PROSTATE CANCER

    BJU International

    Volume 109, Issue 4, February 2012, Pages: 513–514, H. Ballentine Carter

    Version of Record online : 1 FEB 2012, DOI: 10.1111/j.1464-410X.2011.10908.x

  13. You have free access to this content
    Current role of prostate-specific antigen kinetics in managing patients with prostate cancer

    BJU International

    Volume 97, Issue 3, March 2006, Pages: 451–455, SEAMUS J. TEAHAN and LAURENCE H. KLOTZ

    Version of Record online : 10 FEB 2006, DOI: 10.1111/j.1464-410X.2006.05958.x

  14. You have free access to this content
    Evaluation of prediagnostic prostate-specific antigen dynamics as predictors of death from prostate cancer in patients treated conservatively

    International Journal of Cancer

    Volume 128, Issue 10, 15 May 2011, Pages: 2373–2381, M. Frank O'Brien, Angel M. Cronin, Paul A. Fearn, Caroline J. Savage, Brandon Smith, Jason Stasi, Peter T. Scardino, Gabrielle Fisher, Jack Cuzick, Henrik Møller, R. Timothy Oliver, Daniel M. Berney, Christopher S. Foster, James A. Eastham, Andrew J. Vickers, Hans Lilja and on behalf of the Trans-Atlantic Prostate Group

    Version of Record online : 23 JUL 2010, DOI: 10.1002/ijc.25570

  15. Prostate-specific antigen velocity (PSAV): a practical role for PSA?

    ANZ Journal of Surgery

    Volume 79, Issue 10, October 2009, Pages: 703–706, Ruban Thanigasalam, Pascal Mancuso, Kim Tsao and Prem Rashid

    Version of Record online : 28 OCT 2009, DOI: 10.1111/j.1445-2197.2009.05055.x

  16. PSA velocity in conservatively managed BPH: Can it predict the need for BPH-related invasive therapy?

    The Prostate

    Volume 66, Issue 13, 15 September 2006, Pages: 1407–1412, Chaidir A. Mochtar, Lambertus A.L.M. Kiemeney, M. Pilar Laguna, Frans M.J. Debruyne and Jean J.M.C.H. de la Rosette

    Version of Record online : 1 JUN 2006, DOI: 10.1002/pros.20436

  17. You have free access to this content
    Pretreatment prostate-specific antigen velocity is associated with development of distant metastases and prostate cancer mortality in men treated with radiotherapy and androgen-deprivation therapy

    Cancer

    Volume 112, Issue 9, 1 May 2008, Pages: 1941–1948, David Palma, Scott Tyldesley, Tom Pickles and for the Prostate Cohort Outcomes Initiative

    Version of Record online : 13 MAR 2008, DOI: 10.1002/cncr.23388

  18. You have free access to this content
    Relationship between prostate cancer mortality and number of unfavourable risk factors in men treated with definitive brachytherapy

    BJU International

    Volume 106, Issue 6, September 2010, Pages: 809–814, Al V. Taira, Gregory S. Merrick, Robert W. Galbreath, Wayne M. Butler, Jonathan H. Lief and Kent E. Wallner

    Version of Record online : 26 AUG 2010, DOI: 10.1111/j.1464-410X.2010.09269.x

  19. You have free access to this content
    Prostate-specific antigen velocity based risk-adapted discontinuation of prostate cancer screening in elderly men

    BJU International

    Volume 108, Issue 1, July 2011, Pages: 44–48, Ping Tang, Leon Sun, Matthew A. Uhlman, Cary N. Robertson, Thomas J. Polascik and Judd W. Moul

    Version of Record online : 2 NOV 2010, DOI: 10.1111/j.1464-410X.2010.09812.x

  20. You have free access to this content
    Poster Presentation Abstracts

    BJU International

    Volume 113, Issue S4, March 2014, Pages: 51–137,

    Version of Record online : 16 FEB 2014, DOI: 10.1111/bju.12619